Alejandro Luna
Impact in
-
- Chronic Myeloid Leukemia Treatments
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 11
- CAR-T cell therapy research 10
-
- Chronic Myeloid Leukemia Treatments 3
- Co-authors
- Lorenzo Falchi (1 shared paper)Guiomar Bautista (3 shared papers)Fernando de Ory (2 shared papers)Juan Luis Steegmann (3 shared papers)Sara Rodríguez-Mora (3 shared papers)Valentín García‐Gutiérrez (3 shared papers)José Alcamı́ (3 shared papers)María Rosa López‐Huertas (3 shared papers)
- Journals
- Blood (5 papers)Transplantation and Cellular Therapy (3 papers)Blood Advances (2 papers)Transfusion (1 paper)Journal of Clinical Medicine (1 paper)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Alejandro Luna
12 papers receiving 82 citations
Peers
Comparison fields: 5 of 36
- Hematology 21
- Genetics 16
- Oncology 36
- Management of Technology and Innovation 7
- Infectious Diseases 15
Countries citing papers authored by Alejandro Luna
This map shows the geographic impact of Alejandro Luna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Luna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Luna more than expected).
Fields of papers citing papers by Alejandro Luna
This network shows the impact of papers produced by Alejandro Luna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Luna. The network helps show where Alejandro Luna may publish in the future.
Co-authors
The 25 scholars most cited alongside Alejandro Luna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 17 | |
| 2 | 2020 | 14 | |
| 3 | 2024 | 12 | |
| 4 | 2020 | 11 | |
| 5 | 2023 | 7 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 4 | |
| 9 | 2019 | 2 | |
| 10 | 2022 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2026 | 0 | |
| 14 | 2024 | 0 | |
| 15 | 2023 | 0 |
About Alejandro Luna
Alejandro Luna is a scholar working on Oncology, Hematology, Immunology, Molecular Biology and Genetics, having authored 15 papers that have together received 82 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Chronic Myeloid Leukemia Treatments (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Kruppel-like factors research (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Blood transfusion and management (1 paper). The work is most often cited by research in Hematology (21 citations), Genetics (16 citations), Oncology (36 citations), Management of Technology and Innovation (7 citations) and Infectious Diseases (15 citations). Alejandro Luna has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Lorenzo Falchi, Guiomar Bautista, Fernando de Ory, Juan Luis Steegmann, Sara Rodríguez-Mora, Valentín García‐Gutiérrez, José Alcamı́, María Rosa López‐Huertas, Vicente Planelles and Elena Mateos. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Blood Advances, Transfusion and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.